More on crizotinib

N Engl J Med. 2011 Feb 24;364(8):776-7; author reply 778. doi: 10.1056/NEJMc1013325.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anaplastic Lymphoma Kinase
  • Crizotinib
  • False Positive Reactions
  • Humans
  • In Situ Hybridization, Fluorescence
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / genetics
  • Mutation
  • Protein Kinase Inhibitors / therapeutic use*
  • Protein-Tyrosine Kinases / antagonists & inhibitors*
  • Protein-Tyrosine Kinases / genetics
  • Pyrazoles / therapeutic use*
  • Pyridines / therapeutic use*
  • Receptor Protein-Tyrosine Kinases
  • Selection Bias

Substances

  • Protein Kinase Inhibitors
  • Pyrazoles
  • Pyridines
  • Crizotinib
  • Anaplastic Lymphoma Kinase
  • Protein-Tyrosine Kinases
  • Receptor Protein-Tyrosine Kinases